SlideShare a Scribd company logo
Dr. Abrar Ahmad
Post graduate resident
        Surgical unit 1
     BVH Bahawalpur
Pancreatic Pseudocyst
    A fluid collection contained within a well-defined
     capsule of fibrous or granulation tissue or a
     combination of both
    Does not possess an epithelial lining
    Persists > 4 weeks
    May develop in the setting of acute or chronic
     pancreatitis



Bradley III et al. A clinically based classification system for acute pancreatitis: summary
of the International Symposium on Acute Pancreatitis, Arch Surg. 1993;128:586-590
Pancreatic Pseudocyst
Most common cystic lesions of the pancreas,
 accounting for 75-80% of such masses
Location
  Lesser peritoneal sac in proximity to the pancreas
  Large pseudocysts can extend into the paracolic
   gutters, pelvis, mediastinum, neck or scrotum
May be loculated
Composition
Thick fibrous capsule – not a true epithelial lining
Pseudocyst fluid
  Similar electrolyte concentrations to plasma
  High concentration of amylase, lipase, and
    enterokinases such as trypsin
Pathophysiology
Pancreatic ductal disruption 2° to
   1.   Acute pancreatitis – Necrosis
   2.   Chronic pancreatitis – Elevated pancreatic duct
        pressures from strictures or ductal calculi
   3.   Trauma
   4.   Ductal obstruction and pancreatic neoplasms
Pathophysiology
Acute Pancreatitis
  Pancreatic necrosis causes ductular disruption,
   resulting in leakage of pancreatic juice from inflamed
   area of gland, accumulates in space adjacent to
   pancreas
  Inflammatory response induces formation of distinct
   cyst wall composed of granulation tissue, organizes
   with connective tissue and fibrosis
Pathophysiology
Chronic Pancreatitis
  Pancreatic duct chronically obstructed  ongoing
   proximal pancreatic secretion leads to secular dilation
   of duct – true retention cyst
  Formed micro cysts can eventually coalesce and lose
   epithelial lining as enlarge
Presentation
  Symptoms
      Abdominal pain > 3 weeks (80 – 90%)
      Nausea / vomiting
      Early satiety
      Bloating, indigestion
  Signs
      Tenderness
      Abdominal fullness

Cohen et al: Pancreatic pseudocyst. In: Cameron JL, ed. Current Surgical Therapy.
7th ed.; 2001: 543-7
Diagnosis
Clinically suspect a pseudocyst
  Episode of pancreatitis fails to resolve
  Amylase levels persistantly high
  Persistant abdominal pain
  Epigastric mass palpated after pancreatitis
Diagnosis
Labs
  Persistently elevated serum amylase
Plain X-ray
  Not very useful
Ultrasound
  75 -90% sensitive
CT
  Most accurate (sensitivity 90-100%)
Pseudocyst compressing the stomach wall
posteriorly
Sonographic evaluation
EUS showing pseudocyst
Natural History of Pseudocyst
~50% resolve spontaneously
Size
 Nearly all <4cm resolve spontaneously
 >6cm 60-80% persist, necessitate intervention
Cause
 Traumatic, chronic pancreatitis <10% resolve
Multiple cysts – few spont resolve
Duration - Less likely to resolve if persist > 6-8 weeks
Complications
Infection
  S/S – Fever, worsening abd pain, systemic signs of
   sepsis
  CT – Thickening of fibrous wall or air within the cavity
GI obstruction
Perforation
Hemorrhage
Thrombosis – SV (most common)
Pseudoaneurysm formation – Splenic artery
 (most common), GDA, PDA
Treatment
Initial
  NPO
  TPN
  Octreotide
Antibiotics if infected
1/3 – 1/2 resolve spontaneously
Intervention
Indications for drainage
  Presence of symptoms (> 6 wks)
  Enlargement of pseudocyst ( > 6 cm)
  Complications
  Suspicion of malignancy
Intervention
  Percutaneous drainage
  Endoscopic drainage
  Surgical drainage
Percutaneous Drainage
  Continuous drainage until output < 50 ml/day +
     amylase activity ↓
      Failure rate 16%
      Recurrence rates 7%
  Complications
      Conversion into an infected pseudocyst (10%)
      Catheter-site cellulitis
      Damage to adjacent organs
      Pancreatico-cutaneous fistula
      GI hemorrhage

Gumaste et al: Pancreatic pseudocyst. Gastroenterologist 1996 Mar; 4(1): 33-43
Endoscopic Management
Indications
  Mature cyst wall < 1 cm thick
  Adherent to the duodenum or posterior gastric wall
  Previous abd surgery or significant comorbidities
Contraindications
  Bleeding dyscrasias
  Gastric varices
  Acute inflammatory changes that may prevent cyst
   from adhering to the enteric wall
  CT findings
     Thick debris
     Multiloculated pseudocysts
Endoscopic Drainage
Transenteric drainage
  Cystogastrostomy
  Cystoduodenostomy
Transpapillary drainage
  40-70% of pseudocysts communicate with pancreatic
   duct
  ERCP with sphincterotomy, balloon dilatation of
   pancreatic duct strictures, and stent placement beyond
   strictures
Surgical Options
Excision
  Tail of gland & along with proximal strictures – distal
   pancreatectomy & splenectomy
  Head of gland with strictures of pancreatic or bile ducts
   – pancreaticoduodenectomy
External drainage
Internal drainage
  Cystogastrostomy
  Cystojejunostomy
       Permanent resolution confirmed in b/w 91%–97% of patients*
  Cystoduodenostomy
       Can be complicated by duodenal fistula and bleeding at
        anastomotic site
External Drainage
Cysto-jejunostomy
Enucleation of Pseudocyst
Laparoscopic Management
The interface b/w the cyst and the enteric lumen
 must be ≥ 5 cm for adequate drainage
Approaches
  Pancreatitis 2° to biliary etiology → extraluminal
   approach with concurrent laparoscopic
   cholecystectomy
  Non-biliary origin → intraluminal (combined
   laparoscopic/endoscopic) approach.
Which is the preferred intervention?
Surgical drainage is the traditional approach – gold
 standard.
Percutaneous catheter drainage – high chance of
 persistant pancreatic fistula.
Endoscopic drainage - less invasive, becoming more
 popular, technically demanding
.Surgery necessary in complicated pseudocyts, failed
 nonsurgical, and multiple pseudocysts.
THANKS

More Related Content

Pancreatic pseudocyst

  • 1. Dr. Abrar Ahmad Post graduate resident Surgical unit 1 BVH Bahawalpur
  • 2. Pancreatic Pseudocyst A fluid collection contained within a well-defined capsule of fibrous or granulation tissue or a combination of both Does not possess an epithelial lining Persists > 4 weeks May develop in the setting of acute or chronic pancreatitis Bradley III et al. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Arch Surg. 1993;128:586-590
  • 3. Pancreatic Pseudocyst Most common cystic lesions of the pancreas, accounting for 75-80% of such masses Location Lesser peritoneal sac in proximity to the pancreas Large pseudocysts can extend into the paracolic gutters, pelvis, mediastinum, neck or scrotum May be loculated
  • 4. Composition Thick fibrous capsule – not a true epithelial lining Pseudocyst fluid Similar electrolyte concentrations to plasma High concentration of amylase, lipase, and enterokinases such as trypsin
  • 5. Pathophysiology Pancreatic ductal disruption 2° to 1. Acute pancreatitis – Necrosis 2. Chronic pancreatitis – Elevated pancreatic duct pressures from strictures or ductal calculi 3. Trauma 4. Ductal obstruction and pancreatic neoplasms
  • 6. Pathophysiology Acute Pancreatitis Pancreatic necrosis causes ductular disruption, resulting in leakage of pancreatic juice from inflamed area of gland, accumulates in space adjacent to pancreas Inflammatory response induces formation of distinct cyst wall composed of granulation tissue, organizes with connective tissue and fibrosis
  • 7. Pathophysiology Chronic Pancreatitis Pancreatic duct chronically obstructed  ongoing proximal pancreatic secretion leads to secular dilation of duct – true retention cyst Formed micro cysts can eventually coalesce and lose epithelial lining as enlarge
  • 8. Presentation Symptoms Abdominal pain > 3 weeks (80 – 90%) Nausea / vomiting Early satiety Bloating, indigestion Signs Tenderness Abdominal fullness Cohen et al: Pancreatic pseudocyst. In: Cameron JL, ed. Current Surgical Therapy. 7th ed.; 2001: 543-7
  • 9. Diagnosis Clinically suspect a pseudocyst Episode of pancreatitis fails to resolve Amylase levels persistantly high Persistant abdominal pain Epigastric mass palpated after pancreatitis
  • 10. Diagnosis Labs Persistently elevated serum amylase Plain X-ray Not very useful Ultrasound 75 -90% sensitive CT Most accurate (sensitivity 90-100%)
  • 11. Pseudocyst compressing the stomach wall posteriorly
  • 14. Natural History of Pseudocyst ~50% resolve spontaneously Size Nearly all <4cm resolve spontaneously >6cm 60-80% persist, necessitate intervention Cause Traumatic, chronic pancreatitis <10% resolve Multiple cysts – few spont resolve Duration - Less likely to resolve if persist > 6-8 weeks
  • 15. Complications Infection S/S – Fever, worsening abd pain, systemic signs of sepsis CT – Thickening of fibrous wall or air within the cavity GI obstruction Perforation Hemorrhage Thrombosis – SV (most common) Pseudoaneurysm formation – Splenic artery (most common), GDA, PDA
  • 16. Treatment Initial NPO TPN Octreotide Antibiotics if infected 1/3 – 1/2 resolve spontaneously
  • 17. Intervention Indications for drainage Presence of symptoms (> 6 wks) Enlargement of pseudocyst ( > 6 cm) Complications Suspicion of malignancy Intervention Percutaneous drainage Endoscopic drainage Surgical drainage
  • 18. Percutaneous Drainage Continuous drainage until output < 50 ml/day + amylase activity ↓ Failure rate 16% Recurrence rates 7% Complications Conversion into an infected pseudocyst (10%) Catheter-site cellulitis Damage to adjacent organs Pancreatico-cutaneous fistula GI hemorrhage Gumaste et al: Pancreatic pseudocyst. Gastroenterologist 1996 Mar; 4(1): 33-43
  • 19. Endoscopic Management Indications Mature cyst wall < 1 cm thick Adherent to the duodenum or posterior gastric wall Previous abd surgery or significant comorbidities Contraindications Bleeding dyscrasias Gastric varices Acute inflammatory changes that may prevent cyst from adhering to the enteric wall CT findings  Thick debris  Multiloculated pseudocysts
  • 20. Endoscopic Drainage Transenteric drainage Cystogastrostomy Cystoduodenostomy Transpapillary drainage 40-70% of pseudocysts communicate with pancreatic duct ERCP with sphincterotomy, balloon dilatation of pancreatic duct strictures, and stent placement beyond strictures
  • 21. Surgical Options Excision Tail of gland & along with proximal strictures – distal pancreatectomy & splenectomy Head of gland with strictures of pancreatic or bile ducts – pancreaticoduodenectomy External drainage Internal drainage Cystogastrostomy Cystojejunostomy  Permanent resolution confirmed in b/w 91%–97% of patients* Cystoduodenostomy  Can be complicated by duodenal fistula and bleeding at anastomotic site
  • 25. Laparoscopic Management The interface b/w the cyst and the enteric lumen must be ≥ 5 cm for adequate drainage Approaches Pancreatitis 2° to biliary etiology → extraluminal approach with concurrent laparoscopic cholecystectomy Non-biliary origin → intraluminal (combined laparoscopic/endoscopic) approach.
  • 26. Which is the preferred intervention? Surgical drainage is the traditional approach – gold standard. Percutaneous catheter drainage – high chance of persistant pancreatic fistula. Endoscopic drainage - less invasive, becoming more popular, technically demanding .Surgery necessary in complicated pseudocyts, failed nonsurgical, and multiple pseudocysts.